StockData
Acumen Pharmaceuticals, Inc. logo

Acumen Pharmaceuticals, Inc. (ABOS) stock

ABOSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 2/30
$0.19−0.04 (-15.51%)

Close on Nov 18, 2026Market cap $14.06MP/E –Yield –

Acumen Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Acumen Pharmaceuticals

Acumen Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Acumen Pharmaceuticals figures

See a number that looks wrong?